drugset / Trial / NCT05910476
Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)
RandomizedParallel-groupOpen-labelTreatment
Summary
the investigators would like to compare the differences between roschvastin and atovastatin in patients who require high-dose statin/ejetimib to undergo a new generation of drug elution stent implantation for cardiovascular disease and maintain LDL cholesterol below 55 mg/dL.
Timeline
- Start
- 2023-05-03
- Primary completion
- 2026-09-22
- Completion
- 2026-09-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 40 mg | — |
| Comparator | Rosuvastatin | Small molecule | 20 mg | — |
| Comparator | Ezetimibe | Unknown | 10 mg | — |